Susan Young Rojahn

A View from Susan Young Rojahn

Sequencing and Mouse "Avatars" Personalize Cancer Treatment

  • April 9, 2012

Tumor genome sequences and mouse “avatars” may help Mayo Clinic researchers identify the best chemotherapy for individual breast cancer patients in a new study dubbed the BEAUTY project.

In the first phase of the Breast Cancer Genome Guided Therapy Study, Mayo Clinic researchers will sequence the genome of tumors from 200 women with breast cancer. The study will examine the genome both before and after chemotherapy to look for mutations that may bestow cancer cells with one of their most menacing talents—the ability to develop resistance to chemotherapy.

In the second phase of the trial, the researchers will target resistant tumors with drugs tailored to a tumor’s particular mutations. “This is already sort of happening, but not on the scale that we are envisioning at Mayo. We want to make this a standard part of practice to offer to every woman with a high-risk tumor,” said Richard Weinshilboum in a video statement. Key to this kind of personalized therapy is the plummeting cost and time needed to sequence DNA.

Researchers will also look to so-called mouse “avatars” for help in treating every cancer patient as an individual. Cells from each participant’s tumor—before and after chemotherapy—will be transplanted into mice. Clinicians can then test the efficacy of different cancer therapies on these “avatars” of each patient’s cancer.

The latest Insider Conversation is live! Listen to the story behind the story.

Subscribe today
Already a Premium subscriber? Log in.

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Premium.
  • Insider Premium {! insider.prices.premium !}*

    {! insider.display.menuOptionsLabel !}

    Our award winning magazine, unlimited access to our story archive, special discounts to MIT Technology Review Events, and exclusive content.

    See details+

    What's Included

    Bimonthly magazine delivery and unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

    First Look: exclusive early access to important stories, before they’re available to anyone else

    Insider Conversations: listen in on in-depth calls between our editors and today’s thought leaders

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.